Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Zynerba Pharmaceuticals, Inc. - Common Stock (NQ:ZYNE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 10, 2023 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	1.300 (10)
Ask (Size)	1.370 (10)
Prev. Close	1.300
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	53,939,431
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Shares of Harmony Bioscience Are Falling on Friday ↗

October 13, 2023

The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.

Via The Motley Fool

New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies ↗

October 11, 2023

Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc.

Via Benzinga

Performance

More News

Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions

October 04, 2023

From Zynerba Pharmaceuticals, Inc.

Via GlobeNewswire

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

September 29, 2023

From Zynerba Pharmaceuticals, Inc.

Via GlobeNewswire

Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023 ↗

September 26, 2023

Via Benzinga

Cannabis Stock Movers For September 18, 2023 ↗

September 18, 2023

Via Benzinga

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium

September 14, 2023

From Zynerba Pharmaceuticals, Inc.

Via GlobeNewswire

ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE

September 05, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sovos Brands, Inc. (Nasdaq - SOVO), Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc.

August 24, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Cannabis Stock Movers For August 18, 2023 ↗

August 18, 2023

Via Benzinga

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 ↗

August 21, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023 ↗

August 16, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From August 16, 2023 ↗

August 16, 2023

Via Benzinga

Occidental Petroleum To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

August 16, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗

August 15, 2023

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)

August 14, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Cannabis Stock Gainers And Losers From August 14, 2023 ↗

August 14, 2023

Via Benzinga

Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher ↗

August 14, 2023

Via Benzinga

Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today? ↗

August 14, 2023

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 14, 2023

Via Benzinga

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 14, 2023

Via Benzinga

US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet ↗

August 14, 2023

Via Benzinga

Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals ↗

August 14, 2023

Via Benzinga

Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today? ↗

August 14, 2023

Via Benzinga

Dow Falls 50 Points; Monday.com Posts Upbeat Results ↗

August 14, 2023

Via Benzinga

Frequently Asked Questions

Is Zynerba Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Zynerba Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Zynerba Pharmaceuticals, Inc. - Common Stock trade on?

Zynerba Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Zynerba Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Zynerba Pharmaceuticals, Inc. - Common Stock is ZYNE on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.